These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1664006)

  • 1. [Morphological study of the myocardium of mice infected with Coxsackie B1 virus during the treatment with an immunomodulating drug T-activin].
    Kipshidze NN; Tsyplenkova VG; Zhdanov VS; Dzhaparidze MM
    Kardiologiia; 1991 Jul; 31(7):61-5. PubMed ID: 1664006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of T-activin in viral myocarditis in animal experiments].
    Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
    Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
    Hashimoto I; Tatsumi M; Nakagawa M
    Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
    Kishimoto C; Hiraoka Y; Takada H
    Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis.
    Costanzo-Nordin MR; Reap EA; O'Connell JB; Robinson JA; Scanlon PJ
    J Am Coll Cardiol; 1985 Nov; 6(5):1078-82. PubMed ID: 2995470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
    Chang H; Han B; Han XZ
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.
    Kawai C; Matsumori A; Kumagai N; Tokuda M
    Jpn Circ J; 1978 Jan; 42(1):43-7. PubMed ID: 633597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of chronic myocarditis in mice infected with coxsackie B3 viruses.
    Jaśkiewicz K
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):89-97. PubMed ID: 220933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.
    Ilbäck NG; Fohlman J; Slorach S; Friman G
    J Immunol; 1989 May; 142(9):3225-8. PubMed ID: 2540239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrastructural alterations in the myocardium of mice and patients with viral myocarditis].
    Deguchi H; Kitaura Y; Kawamura K
    Kokyu To Junkan; 1993 Apr; 41(4):335-42. PubMed ID: 8390711
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
    Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
    Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
    Glück B; Dahlke K; Zell R; Krumbholz A; Decker M; Lehmann J; Wutzler P
    J Med Virol; 2010 Dec; 82(12):2043-52. PubMed ID: 20981792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trials of treating myocarditis in mice infected with coxsackie B3 viruses.
    Jaśkiewicz K
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):99-103. PubMed ID: 220934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
    Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R
    Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural alterations of the myocardium in coxsackie B-3 virus myocarditis in mice. 18 months follow-up study by transmission and analytical electron microscopy.
    Deguchi H
    Jpn Circ J; 1981 Jun; 45(6):695-712. PubMed ID: 6264176
    [No Abstract]   [Full Text] [Related]  

  • 17. [A pathologic and ultrastructural study of Coxsackie B3 myocarditis in mice].
    Lin JZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Jun; 16(3):159-60. PubMed ID: 2851428
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophysiological and pathological observations on experimental coxsackie B-3 viral myocarditis in mice.
    Yang YZ; Guo Q; Zhou TS; Zhang J; Li L; Jin PY; Wu WZ; Shen JY; Yang JH; Peng BZ
    Chin Med J (Engl); 1993 Feb; 106(2):100-4. PubMed ID: 8389271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.